Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy

INTRODUCTION: Despite established clinical efficacy of PCSK9 inhibitors (PCSK9i) in reducing cardiovascular events, their cost still represents a big matter of debate. We therefore sought to estimate possible impact of PCSK9i therapy from a community taxpayers’ perspective with a budget impact analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Natale Daniele, De Gennaro, Luisa, Tricarico, Lucia, Caldarola, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Care Delivery, Economics and Global Health Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667935/
https://www.ncbi.nlm.nih.gov/pubmed/31413843
http://dx.doi.org/10.1136/openhrt-2019-001018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667935/
https://www.ncbi.nlm.nih.gov/pubmed/31413843
http://dx.doi.org/10.1136/openhrt-2019-001018

Ejemplares similares